A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

NCT00767221 ·Status: COMPLETED ·Phase: PHASE2

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients

NCT06796660 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy

NCT07135219 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1

Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

NCT04939116 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

NCT06137768 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

NCT05517980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

NCT07014826 ·Status: RECRUITING ·Phase: PHASE3

Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study

NCT06924476 ·Status: ACTIVE_NOT_RECRUITING

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

NCT03373461 ·Status: COMPLETED ·Phase: PHASE2

Atrasentan in Patients With IgA Nephropathy

NCT04573478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Telitacicept for IgA Nephropathy (TELIGAN)

NCT05799287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

NCT06676384 ·Status: RECRUITING ·Phase: PHASE4

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

NCT06963827 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

NCT06470191 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

NCT01758120 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

NCT05847920 ·Status: TERMINATED ·Phase: PHASE2

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

NCT05174221 ·Status: COMPLETED ·Phase: PHASE1

Different Immunosuppressive Treatment in iMN

NCT04745728 ·Status: RECRUITING ·Phase: PHASE3

Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease

NCT03157037 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301

NCT05534919 ·Status: COMPLETED ·Phase: PHASE3

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

NCT05707377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

NCT02384317 ·Status: COMPLETED ·Phase: PHASE2

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

NCT04578834 ·Status: COMPLETED ·Phase: PHASE3

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

NCT06291376 ·Status: RECRUITING ·Phase: PHASE3